Early test: how two new drugs mix in the body
NCT ID NCT06890611
Summary
This early-stage study aimed to understand how the body absorbs and processes different versions of an investigational drug called bimagrumab, both by itself and when given with another drug called tirzepatide. It involved 125 healthy volunteers and lasted about 4.5 months. The main goal was to measure drug levels in the blood to see if different formulations or combinations change how the drugs behave.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit
Dallas, Texas, 75247, United States
Conditions
Explore the condition pages connected to this study.